3860 — EPS Creative Health Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$258.48m
- HK$256.81m
- HK$644.62m
- 16
- 53
- 10
- 12
Annual cashflow statement for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 27.8 | 7.14 | -22.7 | -48.2 | -24.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.048 | -0.232 | 5.14 | 5.61 | -10 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.31 | -22.3 | 18 | -0.034 | -8.49 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 24.6 | -12.4 | 4.02 | -38.1 | -28.6 |
| Capital Expenditures | -0.343 | -0.525 | -0.283 | -2.41 | -5.04 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 7.03 | 0.291 | 4.63 | -8.97 | -15.4 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.69 | -0.234 | 4.35 | -11.4 | -20.4 |
| Financing Cash Flow Items | -0.147 | -0.136 | 115 | -24.7 | 29.7 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.39 | -1.81 | 112 | -27.8 | 33.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.8 | -14.3 | 123 | -76.7 | -15.9 |